Judge Dismisses First Seroquel Suits
A federal judge dismisses the first in a series of lawsuits alleging anti-psychotic drug Seroquel causes diabetes.
January 27, 2009 at 07:00 PM
3 minute read
The original version of this story was published on Law.com
Two down, almost 10,000 to go. A Florida federal judge on Wednesday dismissed the first in a series of lawsuits against AstraZeneca over allegations its anti-psychotic drug Seroquel causes diabetes.
Former Seroquel users Linda Guinn and David Haller could not prove they developed diabetes because of the drug, U.S. District Judge Anne Conway said at the hearing. The plaintiffs argued AstraZeneca failed to adequately alert doctors and patients about Seroquel's potential to cause diabetes, even though the company knew about a possible correlation as early as 2000.
London-based AstraZeneca faces roughly 9,000 lawsuits from more than 15,000 plaintiffs throughout the U.S. The trial for one of the two dismissed suits was set to begin in Orlando Feb. 2.
“The company intends to litigate these cases on the individual merits and defend them vigorously,” said AstraZeneca spokesman Tony Jewell in a statement, adding the company was pleased with Wednesday's decision.
The dismissal comes on the heels of Monday's revelation that the Food and Drug Administration demanded AstraZeneca clarify the risk of weight gain and diabetes on the drug's label. The company denies the allegations about unclear labeling and insists it fully disclosed all known risks associated with Seroquel.
Two down, almost 10,000 to go. A Florida federal judge on Wednesday dismissed the first in a series of lawsuits against AstraZeneca over allegations its anti-psychotic drug Seroquel causes diabetes.
Former Seroquel users Linda Guinn and David Haller could not prove they developed diabetes because of the drug, U.S. District Judge Anne Conway said at the hearing. The plaintiffs argued AstraZeneca failed to adequately alert doctors and patients about Seroquel's potential to cause diabetes, even though the company knew about a possible correlation as early as 2000.
London-based AstraZeneca faces roughly 9,000 lawsuits from more than 15,000 plaintiffs throughout the U.S. The trial for one of the two dismissed suits was set to begin in Orlando Feb. 2.
“The company intends to litigate these cases on the individual merits and defend them vigorously,” said AstraZeneca spokesman Tony Jewell in a statement, adding the company was pleased with Wednesday's decision.
The dismissal comes on the heels of Monday's revelation that the Food and Drug Administration demanded AstraZeneca clarify the risk of weight gain and diabetes on the drug's label. The company denies the allegations about unclear labeling and insists it fully disclosed all known risks associated with Seroquel.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All
Coinbase Hit With Antitrust Suit That Seeks to Change How Crypto Exchanges Operate
3 minute read
Baker Botts' Biopharma Client Sues Former In-House Attorney, Others Alleging Extortion Scheme
Trending Stories
- 1Presidential Pardons: A Tool That Can be Used to Move Forward
- 2Some of 2024's Most Notable GC Moves Were Drenched in Drama
- 3Will 2025 Bring a Change to Lawyers' Mandatory Pro Bono Duties Under 'Madden'?
- 4Wholesale Real Estate Transaction Transparency and Protection Act Takes Effect Jan. 4: What You Need to Know
- 5Decision of the Day: 'Attorney's Eyes Only' Protective Order Denied; Good Cause Not Demonstrated
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
